APX005M in Combination With Systemic Pembrolizumab in Patients With Metastatic Melanoma
Clinical trial NCT02706353 · TERMINATED
Trial details
- NCT number
- NCT02706353
- Sponsor
- M.D. Anderson Cancer Center
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-06-02
- Primary completion
- 2025-03-10
- Enrollment
- 34
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.